BioSpace News Archive

Bioventus Inc., a global leader in innovations for active healing, announced the Company plans to file Form 12b-25, Notification of Late Filing, for its Quarterly Report on Form 10-Q for the period ended April 1, 2023, on May 11, 2023.

VolitionRx Limited, a multi-national epigenetics company, announces new research - published in PLOS ONE - which reveals that plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic cancers.

Monopar Therapeutics Inc., a clinicalstage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, announced first quarter 2023 financial results and summarized recent developments.

Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, provided a business update and reported financial results for the first quarter ended March 31, 2023.

LianBio announced that CAMZYOS® has received marketing approval for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy from the Pharmaceutical Administration Bureau of the Macau SAR.

Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the first quarter 2023, ended March 31, 2023.

CureDuchenne Ventures announced funding for MyoGene Bio, LLC, a biotech company developing a novel gene editing therapy for Duchenne muscular dystrophy.

Anebulo Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2023, and recent updates.

UroGen Pharma Ltd. today announced financial results for the first quarter ended March 31, 2023, and provided an overview of recent developments.

Kintara Therapeutics, Inc. today announced financial results for its fiscal third quarter ended March 31, 2023 and provided a corporate update.